Rasagiline

Generic name: Pronounced as (ra sa' ji leen)
Brand names
  • Azilect®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 07/15/2016

Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.

Rasagiline comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take rasagiline at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take rasagiline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of rasagiline and may increase your dose based upon your body's response to this medication.

Do not stop taking rasagiline without talking to your doctor. Your doctor will probably decrease your dose gradually. If you suddenly stop taking rasagiline, you may experience withdrawal symptoms such as a fever; muscle stiffness; unsteadiness, wobbliness, or lack of coordination; or changes in consciousness. Tell your doctor if you experience any of these symptoms when your dose of rasagiline is decreased.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking rasagiline,

  • tell your doctor and pharmacist if you are allergic to rasagiline, any other medications, or any of the ingredients in rasagiline tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking cough and cold products containing dextromethorphan (DM; Delsym, Hold, Robitussin CoughGels, Vicks 44 Cough Relief, in Robitussin DM, others), cyclobenzaprine (Flexeril), meperidine (Demerol), methadone (Dolophine, Methadose), propoxyphene (Darvon, in Darvocet-N, others), St. John's wort, or tramadol (Ultram, in Ultracet). Also tell your doctor if you are taking MAO inhibitors such as phenelzine (Nardil), selegiline (Eldepryl), or tranylcypromine (Parnate) or have stopped taking them within the past two weeks. Your doctor may tell you not to take rasagiline if you are taking one or more of these medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amphetamines (Adderall, Dexedrine, DextroStat); antidepressants; cimetidine (Tagamet); decongestants placed in the eye or nose; diet or weight-control products containing ephedrine; fluoroquinolone antibiotics including ciprofloxacin (Cipro), gatifloxacin (Tequin), levofloxacin (Levaquin), norfloxacin (Noroxin), and ofloxacin (Floxin); fluvoxamine (Luvox); medications to treat asthma; medications to treat high blood pressure; medications to treat mental illness; medications to treat pain; phenylpropanolamine (not available in the U.S.); pseudoephedrine (PediaCare, Sudafed, Suphedrine, others); and ticlopidine (Ticlid). Tell your doctor if you are taking fluoxetine (Prozac, Sarafem) or have stopped taking it within the past 5 weeks. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had high blood pressure, mental illness or psychosis;kidney, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking rasagiline, call your doctor.

  • you should know that rasagiline may cause dizziness, lightheadedness, nausea, sweating, and fainting when you get up too quickly from a lying position. This is more common during the first 2 months of taking rasagiline. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

  • you should know that rasagiline may cause serious, life-threatening high blood pressure when taken with certain medications or foods. Carefully follow your doctor's instructions about medications and foods to be avoided. Call your doctor right away if you have a severe headache, blurred vision, or any of the other symptoms listed below as serious side effects.

  • you should know that people who have Parkinson's disease have a higher risk of melanoma (a type of skin cancer) than people who do not have Parkinson's disease. It is not known whether this increased risk is caused by Parkinson's disease, medications used for Parkinson's disease such as rasagiline, or other factors. You should have regular visits with a dermatologist to examine your skin for melanoma.

  • you should know that some people who took rasagiline or similar medications to treat Parkinson's disease experienced intense urges to gamble, increased sexual urges, and other urges that they were unable to control. Tell your doctor if you experience new or increased gambling urges, increased sexual urges, or other intense urges while taking rasagiline.

You will need to avoid eating foods that contain very high amounts of tyramine, such as aged cheeses (e.g., Stilton or blue cheese) during your treatment with rasagiline. Talk to your doctor or dietitian about which foods you should avoid during your treatment or if you do not feel well after eating or drinking certain foods while taking rasagiline.

Do not take a double dose to make up for a missed one. Skip the missed dose and take your next dose at the usual time the next day.

  • Rasagiline may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • mild headache

    • joint or neck pain

    • heartburn

    • nausea

    • vomiting

    • stomach pain

    • constipation

    • diarrhea

    • loss of appetite

    • weight loss

    • flu-like symptoms

    • fever

    • sweating

    • red, swollen, and/or itchy eyes

    • dry mouth

    • swollen gums

    • unsteadiness, wobbliness, or lack of coordination

    • involuntary, repeated body movements

    • lack of energy

    • sleepiness

    • abnormal dreams

    • depression

    • pain, burning, numbness, or tingling in the hands or feet

    • rash

    • bruising or purple discoloration on skin

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • severe headache

    • blurred vision

    • seizures

    • chest pain

    • shortness of breath or difficulty breathing

    • confusion

    • unconsciousness

    • slow or difficult speech

    • dizziness or faintness

    • weakness or numbness of an arm or leg

    • hallucinating (seeing things or hearing voices that do not exist)

    • extreme restlessness

    • difficulty thinking clearly or understanding reality

  • Rasagiline may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of rasagiline overdose may occur as late as 1 to 2 days after the overdose. Symptoms of overdose may include the following:

  • drowsiness

  • dizziness

  • faintness

  • irritability

  • hyperactivity

  • agitation or restlessness

  • severe headache

  • hallucinating

  • confusion

  • loss of coordination

  • difficulty opening the mouth

  • rigid body spasm that may include an arched back

  • twitching muscles

  • seizures

  • loss of consciousness

  • fast or irregular heart beat

  • pain in the area between the stomach and chest

  • difficulty breathing or slowed breathing

  • diarrhea

  • fever

  • sweating

  • cool, clammy skin

  • shivering

  • increase in pupil size (black circle in middle of eye)

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Rasagiline can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide Rasagiline may increase the hypoglycemic activities of Repaglinide.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Rasagiline can be decreased when it is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Rasagiline can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Rasagiline.
Aminophylline Aminophylline The metabolism of Rasagiline can be decreased when combined with Aminophylline.
Anagrelide Anagrelide The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anagrelide.
Candesartan Candesartan Rasagiline may increase the hypotensive activities of Candesartan.
Cilostazol Cilostazol The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Cilostazol.
Clopidogrel Clopidogrel The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Rasagiline.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Rasagiline can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Guanfacine Guanfacine Rasagiline may increase the hypotensive activities of Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide Rasagiline may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Rasagiline.
Miglitol Miglitol Rasagiline may increase the hypoglycemic activities of Miglitol.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Rasagiline.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Paregoric Paregoric Rasagiline may increase the analgesic activities of Morphine.
Penbutolol Penbutolol Rasagiline may increase the hypotensive activities of Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Rasagiline.
Potassium Potassium Potassium cation may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ranitidine Ranitidine The metabolism of Rasagiline can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Rasagiline is combined with Reserpine.
Rizatriptan Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Rasagiline.
Sumatriptan Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Rasagiline.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tizanidine Tizanidine Rasagiline may increase the orthostatic hypotensive activities of Tizanidine.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Rasagiline.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Famotidine Injection Famotidine Injection The metabolism of Rasagiline can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Rasagiline may increase the serotonergic activities of Hydromorphone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Rasagiline can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Rasagiline can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Rasagiline can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Rasagiline is combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Rasagiline.
Morphine Injection Morphine Injection Rasagiline may increase the analgesic activities of Morphine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Rasagiline may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Rasagiline may increase the hypertensive activities of Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ondansetron Ondansetron The metabolism of Rasagiline can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Rasagiline.
Torsemide Torsemide Rasagiline may increase the hypotensive activities of Torasemide.
Olanzapine Olanzapine The metabolism of Rasagiline can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Rasagiline can be decreased when combined with Alosetron.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Rasagiline.
Eprosartan Eprosartan Rasagiline may increase the hypotensive activities of Eprosartan.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Rasagiline.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Telmisartan Telmisartan Rasagiline may increase the hypotensive activities of Telmisartan.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Anakinra Anakinra The metabolism of Rasagiline can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Rasagiline.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Pentosan polysulfate.
Trimipramine Trimipramine Rasagiline may increase the serotonergic activities of Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Rasagiline can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Rasagiline can be increased when combined with Modafinil.
Perindopril Perindopril Rasagiline may increase the hypotensive activities of Perindopril.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Rasagiline.
Epinephrine Injection Epinephrine Injection Rasagiline may increase the hypertensive activities of Epinephrine.
Eplerenone Eplerenone Rasagiline may increase the orthostatic hypotensive activities of Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Escitalopram.
Olmesartan Olmesartan Rasagiline may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide Zonisamide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection Adalimumab Injection The metabolism of Rasagiline can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Rasagiline is combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Rasagiline may increase the hypertensive activities of Dexmethylphenidate.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Rasagiline.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Rasagiline.
Vardenafil Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Rasagiline.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Rasagiline can be decreased when combined with Interferon beta-1a.
Memantine Memantine Memantine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Rasagiline can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may increase the hypotensive activities of Rasagiline.
Frovatriptan Frovatriptan The metabolism of Rasagiline can be decreased when combined with Frovatriptan.
Gemifloxacin Gemifloxacin The metabolism of Rasagiline can be decreased when combined with Gemifloxacin.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Rasagiline.
Infliximab Injection Infliximab Injection The metabolism of Rasagiline can be increased when combined with Infliximab.
Protriptyline Protriptyline Rasagiline may increase the serotonergic activities of Protriptyline.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Rasagiline is combined with Duloxetine.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trospium Trospium Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Rasagiline may increase the hypotensive activities of Bosentan.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Rasagiline can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Rasagiline can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Rasagiline is combined with Eszopiclone.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Rasagiline may increase the hypoglycemic activities of Insulin aspart.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Solifenacin Solifenacin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir Valganciclovir Rasagiline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Rasagiline may increase the hypertensive activities of Amphetamine.
Entecavir Entecavir The metabolism of Rasagiline can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Rasagiline can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection Rasagiline may increase the hypoglycemic activities of Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Exenatide Injection Exenatide Injection Rasagiline may increase the hypoglycemic activities of Exenatide.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Rasagiline.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Rasagiline.
Darifenacin Darifenacin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Rasagiline is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Rasagiline can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Rasagiline can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine Rasagiline may increase the hypertensive activities of Phenylephrine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Rasagiline.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Rasagiline may increase the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Rasagiline can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Rasagiline can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Albuterol Albuterol Salbutamol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Rasagiline.
Bortezomib Bortezomib The metabolism of Rasagiline can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Rasagiline may increase the orthostatic hypotensive activities of Clofarabine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Primaquine Primaquine The metabolism of Rasagiline can be decreased when combined with Primaquine.
Aliskiren Aliskiren Rasagiline may increase the hypotensive activities of Aliskiren.
Pemetrexed Injection Pemetrexed Injection Rasagiline may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Rasagiline.
Lisdexamfetamine Lisdexamfetamine Rasagiline may increase the hypertensive activities of Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Sorafenib Sorafenib The metabolism of Rasagiline can be decreased when combined with Sorafenib.
Sunitinib Sunitinib Rasagiline may increase the hypoglycemic activities of Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Rasagiline is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Rasagiline may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Rasagiline can be decreased when combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Rasagiline can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Rasagiline can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Budesonide Budesonide Budesonide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rasagiline.
Doripenem Injection Doripenem Injection Rasagiline may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Rasagiline may increase the orthostatic hypotensive activities of Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Rasagiline may increase the serotonergic activities of Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nebivolol Nebivolol Rasagiline may increase the hypotensive activities of Nebivolol.
Tretinoin Tretinoin Rasagiline may increase the orthostatic hypotensive activities of Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Rasagiline.
Flecainide Flecainide The metabolism of Rasagiline can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Rasagiline can be increased when combined with Certolizumab pegol.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Rasagiline can be decreased when combined with Praziquantel.
Methylnaltrexone Injection Methylnaltrexone Injection Rasagiline may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Rasagiline.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Rasagiline.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rasagiline.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Rasagiline.
Milnacipran Milnacipran Rasagiline may increase the serotonergic activities of Milnacipran.
Plerixafor Injection Plerixafor Injection Rasagiline may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol Rasagiline may increase the hypotensive activities of Betaxolol.
Iloperidone Iloperidone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Prasugrel.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Rasagiline is combined with Lacosamide.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The risk or severity of hypertension can be increased when Rasagiline is combined with Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
Pralatrexate Injection Pralatrexate Injection Rasagiline may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Rasagiline.
Saxagliptin Saxagliptin Rasagiline may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Rasagiline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Rasagiline.
Topotecan Topotecan Topotecan may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Rasagiline can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Rasagiline.
Asenapine Asenapine The metabolism of Asenapine can be decreased when combined with Rasagiline.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Rasagiline.
Albendazole Albendazole The metabolism of Rasagiline can be decreased when combined with Albendazole.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Rasagiline.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection Rasagiline may increase the hypoglycemic activities of Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Rasagiline can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Rasagiline is combined with Dalfampridine.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Lurasidone Lurasidone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Rasagiline can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Rasagiline.
Ipilimumab Injection Ipilimumab Injection Rasagiline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Rasagiline may increase the orthostatic hypotensive activities of Aldesleukin.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Azilsartan Azilsartan Rasagiline may increase the orthostatic hypotensive activities of Azilsartan medoxomil.
Roflumilast Roflumilast Rasagiline may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin Rasagiline may increase the hypoglycemic activities of Linagliptin.
Abiraterone Abiraterone The serum concentration of Rasagiline can be increased when it is combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Ticagrelor.
Ruxolitinib Ruxolitinib Rasagiline may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Rasagiline can be increased when it is combined with Vemurafenib.
Deferiprone Deferiprone Rasagiline may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Rasagiline.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Rasagiline.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ambrisentan Ambrisentan Rasagiline may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Fondaparinux.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Rasagiline.
Iloprost Iloprost Rasagiline may increase the orthostatic hypotensive activities of Iloprost.
Enzalutamide Enzalutamide Rasagiline may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Rasagiline may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teriflunomide Teriflunomide The serum concentration of Rasagiline can be decreased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin Rasagiline may increase the hypoglycemic activities of Mecasermin.
Teduglutide Injection Teduglutide Injection Rasagiline may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Icosapent ethyl.
Alogliptin Alogliptin Rasagiline may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Rasagiline is combined with Pomalidomide.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Apixaban.
Canagliflozin Canagliflozin Rasagiline may increase the orthostatic hypotensive activities of Canagliflozin.
Methazolamide Methazolamide Rasagiline may increase the orthostatic hypotensive activities of Methazolamide.
Trametinib Trametinib Rasagiline may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Rasagiline may increase the serotonergic activities of Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Rasagiline.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Rasagiline.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection Rasagiline may increase the orthostatic hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir The metabolism of Rasagiline can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Rasagiline may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Rasagiline may increase the orthostatic hypotensive activities of Dapagliflozin.
Apremilast Apremilast The metabolism of Rasagiline can be increased when combined with Apremilast.
Droxidopa Droxidopa Rasagiline may increase the hypertensive activities of Droxidopa.
Siltuximab Injection Siltuximab Injection The metabolism of Rasagiline can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection Rasagiline may increase the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Rasagiline is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The metabolism of Rasagiline can be increased when combined with Belinostat.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Empagliflozin Empagliflozin Rasagiline may increase the orthostatic hypotensive activities of Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Vorapaxar.
Hydrocodone Hydrocodone Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Rasagiline may increase the hypoglycemic activities of Dulaglutide.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Rasagiline can be decreased when combined with Peginterferon beta-1a.
Methamphetamine Methamphetamine Rasagiline may increase the hypertensive activities of Metamfetamine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Rasagiline is combined with Tasimelteon.
Riociguat Riociguat Rasagiline may increase the hypotensive activities of Riociguat.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Rasagiline.
Secukinumab Injection Secukinumab Injection The metabolism of Rasagiline can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Rasagiline may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Rasagiline can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Rasagiline can be decreased when combined with Lenvatinib.
Dinutuximab Injection Dinutuximab Injection Rasagiline may increase the orthostatic hypotensive activities of Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Rasagiline is combined with Haloperidol.
Amiloride Amiloride Rasagiline may increase the orthostatic hypotensive activities of Amiloride.
Macitentan Macitentan Rasagiline may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Rasagiline.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Rasagiline.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Rasagiline.
Penicillin G Procaine Injection Penicillin G Procaine Injection Rasagiline may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin degludec.
Osimertinib Osimertinib The serum concentration of Rasagiline can be decreased when it is combined with Osimertinib.
Ixazomib Ixazomib Rasagiline may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Rasagiline may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Rasagiline.
Midodrine Midodrine Rasagiline may increase the hypertensive activities of Midodrine.
Selexipag Selexipag Rasagiline may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin The therapeutic efficacy of Rasagiline can be decreased when used in combination with Pimavanserin.
Obeticholic Acid Obeticholic Acid The metabolism of Rasagiline can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Rasagiline may increase the orthostatic hypotensive activities of Furosemide.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Rasagiline.
Lixisenatide Injection Lixisenatide Injection Rasagiline may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Rasagiline may increase the serotonergic activities of Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Deutetrabenazine.
Valbenazine Valbenazine Rasagiline may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Rasagiline is combined with Safinamide.
Naldemedine Naldemedine Rasagiline may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The serum concentration of Rasagiline can be increased when it is combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Rasagiline can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Rasagiline may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Rasagiline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Betrixaban.
Semaglutide Injection Semaglutide Injection Rasagiline may increase the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Rasagiline.
Apalutamide Apalutamide Rasagiline may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Rasagiline.
Baricitinib Baricitinib Rasagiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Rasagiline can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Rasagiline may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Rasagiline.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rasagiline.
Stiripentol Stiripentol The metabolism of Rasagiline can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Rasagiline can be decreased when used in combination with Gilteritinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Rasagiline may increase the orthostatic hypotensive activities of Paclitaxel.
Rifamycin Rifamycin The metabolism of Rasagiline can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Rasagiline may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Rasagiline can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of hypertension can be increased when Rasagiline is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Caplacizumab.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Rasagiline.
Triclabendazole Triclabendazole The metabolism of Rasagiline can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Rasagiline.
Pitolisant Pitolisant The metabolism of Pitolisant can be increased when combined with Rasagiline.
Phenytoin Injection Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Rasagiline.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Rasagiline can be increased when combined with Fosphenytoin.
Lumateperone Lumateperone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Lasmiditan.
Cenobamate Cenobamate The therapeutic efficacy of Cenobamate can be decreased when used in combination with Rasagiline.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Rasagiline.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Rasagiline is combined with Selpercatinib.
Capmatinib Capmatinib The metabolism of Rasagiline can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Rasagiline is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Rasagiline.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Rasagiline can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Rasagiline is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Theophylline Theophylline The metabolism of Rasagiline can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trazodone Trazodone Rasagiline may increase the serotonergic activities of Trazodone.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Phenobarbital Phenobarbital The risk or severity of adverse effects can be increased when Phenobarbital is combined with Rasagiline.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Rasagiline.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Rasagiline.
Primidone Primidone The metabolism of Rasagiline can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Rasagiline is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Rasagiline is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Chlorpromazine.
Diazepam Diazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Rasagiline.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Rasagiline.
Clorazepate Clorazepate The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clorazepic acid.
Lorazepam Lorazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lorazepam.
Phenoxybenzamine Phenoxybenzamine Rasagiline may increase the hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine The metabolism of Rasagiline can be decreased when combined with Carmustine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Rasagiline.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Rasagiline.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Rasagiline.
Bromocriptine Bromocriptine Rasagiline may increase the hypertensive activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of adverse effects can be increased when Rasagiline is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Rasagiline.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Rasagiline.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Rasagiline.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rasagiline.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Prochlorperazine Prochlorperazine The therapeutic efficacy of Prochlorperazine can be decreased when used in combination with Rasagiline.
Thioridazine Thioridazine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Thioridazine.
Trifluoperazine Trifluoperazine The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Rasagiline.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Oxycodone Oxycodone Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Rasagiline.
Oxybutynin Oxybutynin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Rasagiline is combined with Maprotiline.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The therapeutic efficacy of Perphenazine can be decreased when used in combination with Rasagiline.
Azathioprine Azathioprine The metabolism of Rasagiline can be decreased when combined with Azathioprine.
Fluphenazine Fluphenazine The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Rasagiline.
Phentermine Phentermine Rasagiline may increase the hypertensive activities of Phentermine.
Methylphenidate Methylphenidate Rasagiline may increase the hypertensive activities of Methylphenidate.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Rasagiline is combined with Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rasagiline.
Molindone Molindone The therapeutic efficacy of Molindone can be decreased when used in combination with Rasagiline.
Methyldopa Methyldopa Rasagiline may decrease the hypotensive activities of Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Rasagiline.
Prazosin Prazosin Rasagiline may increase the hypotensive activities of Prazosin.
Hydralazine Hydralazine Rasagiline may increase the hypotensive activities of Hydralazine.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Warfarin Warfarin Rasagiline may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clonazepam.
Promethazine Promethazine The risk or severity of extrapyramidal symptoms can be increased when Promethazine is combined with Rasagiline.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Rasagiline can be increased when combined with Griseofulvin.
Digoxin Digoxin Rasagiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Loxapine.
Chloroquine Chloroquine Chloroquine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinine Quinine The metabolism of Rasagiline can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Rasagiline.
Triamterene Triamterene Rasagiline may increase the orthostatic hypotensive activities of Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Rasagiline may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Rasagiline may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Rasagiline may increase the hypotensive activities of Metolazone.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may increase the hypotensive activities of Rasagiline.
Desipramine Desipramine Rasagiline may increase the serotonergic activities of Desipramine.
Amitriptyline Amitriptyline Rasagiline may increase the serotonergic activities of Amitriptyline.
Imipramine Imipramine Rasagiline may increase the serotonergic activities of Imipramine.
Probenecid Probenecid Probenecid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinidine Quinidine The serum concentration of Rasagiline can be increased when it is combined with Quinidine.
Procainamide Procainamide Rasagiline may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The metabolism of Rasagiline can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Rifampin Rifampin The metabolism of Rasagiline can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Rasagiline can be decreased when combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Rasagiline can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Rasagiline can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Rasagiline.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Methimazole Methimazole The metabolism of Rasagiline can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dextromethorphan Dextromethorphan The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the serotonergic activities of Rasagiline.
Baclofen Baclofen The risk or severity of hypotension can be increased when Baclofen is combined with Rasagiline.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Cyproheptadine Cyproheptadine Rasagiline may increase the anticholinergic activities of Cyproheptadine.
Clemastine Clemastine Rasagiline may increase the anticholinergic activities of Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Rasagiline.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Rasagiline.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Rasagiline.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Methyclothiazide Methyclothiazide Rasagiline may increase the orthostatic hypotensive activities of Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide Rasagiline may increase the hypotensive activities of Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Rasagiline.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Rasagiline.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Rasagiline.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Rasagiline.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Rasagiline may increase the hypotensive activities of Propranolol.
Minoxidil Minoxidil Rasagiline may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Rasagiline may increase the hypertensive activities of Pseudoephedrine.
Nortriptyline Nortriptyline Rasagiline may increase the serotonergic activities of Nortriptyline.
Spironolactone Spironolactone Rasagiline may increase the orthostatic hypotensive activities of Spironolactone.
Amphotericin B Injection Amphotericin B Injection Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nadolol Nadolol Rasagiline may increase the hypotensive activities of Nadolol.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rasagiline.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Rasagiline.
Flavoxate Flavoxate Flavoxate may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Papaverine Papaverine Rasagiline may increase the orthostatic hypotensive activities of Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Rasagiline can be decreased when combined with Fluorouracil.
Colchicine Colchicine Rasagiline may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Rasagiline can be decreased when combined with Dacarbazine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Rasagiline.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Rasagiline can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Rasagiline is combined with Pyrantel.
Captopril Captopril Rasagiline may increase the hypotensive activities of Captopril.
Dipyridamole Dipyridamole Rasagiline may increase the orthostatic hypotensive activities of Dipyridamole.
Isoxsuprine Isoxsuprine Rasagiline may increase the orthostatic hypotensive activities of Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid Rasagiline may increase the orthostatic hypotensive activities of Etacrynic acid.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Metoprolol Metoprolol Rasagiline may increase the hypotensive activities of Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Thiothixene Thiothixene The therapeutic efficacy of Thiothixene can be decreased when used in combination with Rasagiline.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Rasagiline.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Rasagiline.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Rasagiline.
Dicyclomine Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Hyoscyamine Hyoscyamine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Diltiazem Diltiazem Rasagiline may increase the hypotensive activities of Diltiazem.
Nifedipine Nifedipine Rasagiline may increase the orthostatic hypotensive activities of Nifedipine.
Timolol Timolol Rasagiline may increase the hypotensive activities of Timolol.
Verapamil Verapamil Rasagiline may increase the orthostatic hypotensive activities of Verapamil.
Atenolol Atenolol Rasagiline may increase the hypotensive activities of Atenolol.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Rasagiline.
Cisplatin Injection Cisplatin Injection Rasagiline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Bumetanide Bumetanide Rasagiline may increase the orthostatic hypotensive activities of Bumetanide.
Streptozocin Streptozocin The metabolism of Rasagiline can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Rasagiline can be decreased when combined with Etoposide.
Glyburide Glyburide Rasagiline may increase the hypoglycemic activities of Glyburide.
Glipizide Glipizide Glipizide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Indapamide Indapamide Rasagiline may increase the hypotensive activities of Indapamide.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Rasagiline can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding and hemorrhage can be increased when Pentoxifylline is combined with Rasagiline.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Labetalol Labetalol Rasagiline may increase the hypotensive activities of Labetalol.
Auranofin Auranofin Auranofin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Rasagiline can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz Rasagiline may increase the hypotensive activities of Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pimozide Pimozide The therapeutic efficacy of Pimozide can be decreased when used in combination with Rasagiline.
Enalapril Enalapril Rasagiline may increase the hypotensive activities of Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Amiodarone Amiodarone Rasagiline may increase the orthostatic hypotensive activities of Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Buspirone Buspirone The risk or severity of hypertension can be increased when Rasagiline is combined with Buspirone.
Ciprofloxacin Ciprofloxacin The serum concentration of Rasagiline can be increased when it is combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Fluoxetine Fluoxetine The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Fluoxetine.
Nimodipine Nimodipine Rasagiline may increase the hypotensive activities of Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Rasagiline can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clozapine.
Estazolam Estazolam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Estazolam.
Ofloxacin Ofloxacin The metabolism of Rasagiline can be decreased when combined with Ofloxacin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Benazepril Benazepril Rasagiline may increase the hypotensive activities of Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Felodipine Felodipine Rasagiline may increase the hypotensive activities of Felodipine.
Fosinopril Fosinopril Rasagiline may increase the hypotensive activities of Fosinopril.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinapril Quinapril Rasagiline may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Rasagiline may increase the hypotensive activities of Ramipril.
Amlodipine Amlodipine Rasagiline may increase the hypotensive activities of Amlodipine.
Lisinopril Lisinopril Rasagiline may increase the hypotensive activities of Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sotalol Sotalol Rasagiline may increase the orthostatic hypotensive activities of Sotalol.
Bisoprolol Bisoprolol Rasagiline may increase the hypotensive activities of Bisoprolol.
Zolpidem Zolpidem Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Rasagiline may increase the hypotensive activities of Doxazosin.
Terazosin Terazosin Rasagiline may increase the hypotensive activities of Terazosin.
Isradipine Isradipine Rasagiline may increase the hypotensive activities of Isradipine.
Omeprazole Omeprazole The metabolism of Rasagiline can be increased when combined with Omeprazole.
Cisapride Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Rasagiline.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Rasagiline.
Venlafaxine Venlafaxine Rasagiline may increase the serotonergic activities of Venlafaxine.
Fluvoxamine Fluvoxamine The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.
Nefazodone Nefazodone Rasagiline may increase the serotonergic activities of Nefazodone.
Lamotrigine Lamotrigine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lamotrigine.
Losartan Losartan Rasagiline may increase the hypotensive activities of Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tramadol Tramadol The risk or severity of serotonin syndrome and seizure can be increased when Rasagiline is combined with Tramadol.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Moexipril Moexipril Rasagiline may increase the hypotensive activities of Moexipril.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nicardipine Nicardipine Rasagiline may increase the hypotensive activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.
Ticlopidine Ticlopidine The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Ticlopidine.
Metformin Metformin Metformin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Dalteparin.
Nisoldipine Nisoldipine Rasagiline may increase the hypotensive activities of Nisoldipine.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Riluzole Riluzole The metabolism of Rasagiline can be decreased when combined with Riluzole.
Amifostine Injection Amifostine Injection Rasagiline may increase the orthostatic hypotensive activities of Amifostine.
Acarbose Acarbose Acarbose may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Glimepiride Glimepiride Rasagiline may increase the hypoglycemic activities of Glimepiride.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ritonavir Ritonavir The metabolism of Rasagiline can be increased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Clomipramine Clomipramine Rasagiline may increase the serotonergic activities of Clomipramine.
Zafirlukast Zafirlukast The serum concentration of Rasagiline can be increased when it is combined with Zafirlukast.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Mirtazapine Mirtazapine Rasagiline may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Rasagiline may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The therapeutic efficacy of Rasagiline can be decreased when used in combination with Topiramate.
Zileuton Zileuton The metabolism of Rasagiline can be decreased when combined with Zileuton.
Valsartan Valsartan Rasagiline may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Rasagiline can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Rasagiline may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Rasagiline.
Carvedilol Carvedilol Rasagiline may increase the hypotensive activities of Carvedilol.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Flutamide Flutamide The metabolism of Rasagiline can be decreased when combined with Flutamide.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Rasagiline.
Sertraline Sertraline The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Sertraline.
Propafenone Propafenone The metabolism of Rasagiline can be decreased when combined with Propafenone.
Irbesartan Irbesartan Rasagiline may increase the hypotensive activities of Irbesartan.
Tamsulosin Tamsulosin Rasagiline may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole Rasagiline may increase the sedative activities of Ropinirole.
Finasteride Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Rasagiline.
Quetiapine Quetiapine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Rasagiline.
Paroxetine Paroxetine Rasagiline may increase the serotonergic activities of Paroxetine.
Tolcapone Tolcapone Rasagiline may increase the orthostatic hypotensive activities of Tolcapone.
Citalopram Citalopram The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Citalopram.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Rasagiline can be decreased when combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of hypotension can be increased when Sildenafil is combined with Rasagiline.
Pioglitazone Pioglitazone Rasagiline may increase the hypoglycemic activities of Pioglitazone.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Rosiglitazone Rosiglitazone The metabolism of Rasagiline can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Tolterodine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Thalidomide Thalidomide Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Rasagiline.
Rabeprazole Rabeprazole The metabolism of Rasagiline can be increased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Rasagiline can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists